Michiel Van de Voorde

Research output

Research output per year 2018 2022 2023 2024

• 13 Article
• 11 In-proceedings paper
• 2 Literature review
• 1 Third partyreport
• 1 More
  • 1 Special issue

Research output per year

Research output per year

Search results

• 2024

  Preclinical evaluation of gastrin-releasing peptide receptor antagonists labeled with 161Tb and 177Lu: A comparative study

  Holzleitner, N., Cwojdzinski, T., Beck, R., Urtz-Urban, N., Hillhouse, C. C., Grundler, P. V., van der Meulen, N. P., Talip, Z., Ramaekers, S., Van de Voorde, M., Ponsard, B., Casini, A. & Günther, T., Mar 2024, In: Journal of Nuclear Medicine. 65, 3, p. 481-484 4 p., 266233.

  Research output › peer-review

  Open Access

• Preclinical evaluation of MC1R targeting theranostic pair [¹⁵⁵Tb]Tb-crown-αMSH and [¹⁶¹Tb]Tb-crown-αMSH

  Wharton, L., McNeil, S. W., Zhang, C., Engudar, G., Van de Voorde, M., Zeisler, J., Koniar, H., Sekar, S., Yuan, Z., Schaffer, P., Radchenko, V., Ooms, M., Kunz, P., Bénard, F. & Yang, H., Sep 2024, In: Nuclear Medicine and Biology. 136-137, 11 p., 108925.

  Research output › peer-review

  Open Access

• Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development

  Koniar, H., McNeil, S., Wharton, L., Ingham, A., van de Voorde, M., Ooms, M., Sekar, S., Rodriguez-Rodriguez, C., Kunz, P., Radchenko, V., Rahmim, A., Uribe, C., Yang, H. & Schaffer, P., Dec 2024, In: EJNMMI Physics. 11, 1, 18 p., 77.

  Research output › peer-review

  Open Access

• Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside

  Van Laere, C., Koole, M., Deroose, C. M., Van de Voorde, M., Baete, K., Cocolios, T. E., Duchemin, C., Ooms, M. & Cleeren, F., 17 Feb 2024, In: Theranostics. 14, 4, p. 1720-1743 24 p.

  Research output › peer-review

  Open Access
• 2023

  Comparative Study of a Decadentate Acyclic Chelate, HOPO‑O10, and Its Octadentate Analogue, HOPO‑O8, for Radiopharmaceutical Applications

  Carbo-Bague, I., Li, C., McNeil, B. L., Gao, Y., McDonagh, A. W., Van de Voorde, M., Ooms, M., Kunz, P., Yang, H., Radchenko, V., Schreckenbach, G. & Ramogida, C. F., 18 Dec 2023, In: Inorganic Chemistry. 62, 50, p. 20549-20566 18 p., 2c03671.

  Research output › peer-review

  Open Access

• Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb

  Morgat, C., Van de Voorde, M., Bodin, S., Champion, C. & Hindié, E., Nov 2023, In: Médecine Nucléaire. 47, 6, p. 333-338 6 p.

  Research output › peer-review

  Open Access

• P-232 - Nanosized crystalline vehicle for targeted radionuclide therapy

  Lemaître, T., Opsomer, T., Ooms, M., Burgoyne, A., Van de Voorde, M., Cardinaels, T. & Parac-Vogt, T. N., 1 Dec 2023, Nuclear Medicine and Biology: Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2023. Supplement ed. Elsevier, Vol. 126–127. p. S226 1 p. 108696. (Nuclear Medicine and Biology; vol. 126-127).

  Research output › peer-review

  Open Access

• P-260 - Validating the impact of metal contaminants on the radiolabeling of DOTATATE with 161Tb

  Opsomer, T., Vermeulen, K., Van de Voorde, M., Ramaekers, S., Segers, C., Coolkens, A. & Ooms, M., 1 Dec 2023, Nuclear Medicine and Biology: Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2023. Supplement ed. Elsevier, Vol. 126–127. p. S246-S247 2 p. 108723. (Nuclear Medicine and Biology; vol. 126-127).

  Research output › peer-review

• Preclinical evaluation of [155/161Tb] Tb-Crown-TATE - a novel SPECT imaging theranostic agent targeting neuroendocrine tumours

  Wharton, L., McNeil, S. W., Merkens, H., Yuan, Z., Van de Voorde, M., Engudar, G., Ingham, A., Koniar, H., Rodriguez-Rodriguez, C., Radchenko, V., Ooms, M., Kunz, P., Bénard, F., Schaffer, P. & Yang, H., Apr 2023, In: Molecules. 28, 7, 16 p., 3155.

  Research output › peer-review

  Open Access
• 2022

  A simple and automated method for 161Tb purification and ICP‑MS analysis of 161Tb

  McNeil, S. W., Van de Voorde, M., Zhang, C., Ooms, M., Bénard, F., Radchenko, V. & Yang, H., 2 Dec 2022, In: EJNMMI Radiopharmacy and Chemistry. 7, 17 p., 31.

  Research output › peer-review

  Open Access

• Development of an in-house 188W/188Re generator for rhenium-188 production and radiolabelling studies

  Melis, D., Opsomer, T., Ponsard, B., Burgoyne, A., Gasser, G., Van de Voorde, M. & Ooms, M., Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). Elsevier, Vol. 114-115/S. p. S38 1 p. P-11. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Development of targeted 161Tb-radiolabeled nanoparticles

  Lemaître, T., Ooms, M., Opsomer, T., Van de Voorde, M., Cardinaels, T. & Parac-Vogt, T. N., 1 Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). Elsevier, Vol. 114-115/S. p. S69 1 p. P-73. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study

  Opsomer, T., Van de Voorde, M., Vermeulen, K., Ramaekers, S., Burgoyne, A. & Ooms, M., 8 Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). 2022 ed. Elsevier, Vol. 114-115/S. p. S57-S58 2 p. P-53. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy

  Cassells, I., Van de Voorde, M., Vermeulen, K., Rodriguez Pérez, S., Segers, C., Cawthorne, C., Deroose, C., Cardinaels, T., Bormans, G., Ooms, M. & Cleeren, F., 8 Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). Elsevier, Vol. 114-115/S. p. S50 1 p. P-37. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Exploring the potential of high-molar activity Samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE

  Vermeulen, K., Van de Voorde, M., Segers, C., Coolkens, A., Rodriguez Perez, S., Duchemin, C., Crabbé, M., Opsomer, T., Saldarriaga Vargas, C., Reinhard, H., Lambert, L., Bernerd, C., Burgoyne, A., Cocolios, T. E., Stora, T. & Ooms, M., 18 Nov 2022, In: Pharmaceutics. 14, p. 1-15 15 p., 2566.

  Research output › peer-review

  Open Access

• Mild condition radiolabelling and in vivo stability of nanobody constructs with terbium-161 and terbium-155

  Cassells, I., Van de Voorde, M., Webster, B., Ivanov, P., Burgoyne, A., Cawthorne, C., Deroose, C., Cardinaels, T., Bormans, G., Cleeren, F. & Ooms, M., 22 May 2022, Nuclear Medicine and Biology. Supplement ed. Elsevier, Vol. 108-109. p. S53-S54 2 p. P-004. (Nuclear Medicine and Biology; vol. 108).

  Research output › peer-review

  Open Access

• O-27 - Using high-specific activity Samarium-153 for the development of [153Sm] Sm DOTA-TATE for targeted radionuclide therapy of neuroendocrine tumors

  Vermeulen, K., Van de Voorde, M., Daems, N., Duchemin, C., Rodriguez Pérez, S., Crabbé, M., Reinhard, H., Ponsard, B., Geenen, L., Nonnekens, J., Lambert, L., Bernerd, C., Burgoyne, A., Cocolios, T. E., Stora, T. & Ooms, M., May 2022, In: Nuclear Medicine and Biology. 108-109, Supplement, p. S20 1 p.

  Research output › peer-review

  Open Access

• Standards for clinical translation: Deliverable D4.1

  Bourdeau, C., Haddad, F., Viertl, D., Delvill, C., Naidoo, C., Sorborg Pedersen, K., Jensen, M., Köster, U., Galambos Correia, J., Gano, L., Bruchertseifer, F., Baete, K., Decristoforo, C., Feldkamp Hayashi, S., Mikolajczak, R., Collins, S., Geistlich, S., van der Meulen, N. P., Ponsard, B. & Van de Voorde, M. & 1 others, Campillos, M., 31 May 2022, PRISMAP. 59 p. (PRISMAP reports; no. D4.1)

  Research output › peer-review

  Open Access
• 2021

  Production of Sm-153 with high specific activity for targeted radionuclide therapy

  Van de Voorde, M., Duchemin, C., Reinhard, H., Lambert, L., Chevallay, E., Cocolios, T. E., Cardinaels, T., Ponsard, B., Ooms, M., Stora, T. & Burgoyne, A., 24 Sep 2021, European Journal of Nuclear Medicine and Molecular Imaging (2021): Annual Congress of the European Association of Nuclear Medicine, October 20-23, 2021. Supplement 1 ed. Springer, Vol. 48. p. S410-S410 1 p. ESP-050

  Research output › peer-review

  Open Access

• Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

  Van de Voorde, M., Duchemin, C., Reinhard, H., Lambert, L., Chevallay, E., Schneider, T., Van Stenis, M., Cocolios, T. E., Cardinaels, T., Ponsard, B., Ooms, M., Stora, T. & Burgoyne, A., 19 Jul 2021, In: Frontiers in Medicine. 8, p. 1-9 9 p., 675221.

  Research output › peer-review

  Open Access

• Radiolabeling of human serum albumin with terbium-161 using mild conditions and evaluation of in vivo Stability

  Cassells, I., Ahenkorah, S., Burgoyne, A., Van de Voorde, M., Deroose, C., Cardinaels, T., Bormans, G., Ooms, M. & Cleeren, F., 18 Aug 2021, In: Frontiers in Medicine. 8, p. 1-12 12 p., 675122.

  Research output › peer-review

  Open Access
• 2020

  Development of an in-house 188W/188Re generator

  Van de Voorde, M., Burgoyne, A., Ponsard, B., Elema, D., Cardinaels, T. & Ooms, M., 30 Oct 2020, European Journal of Nuclear Medicine and Molecular Imaging. suppl. 1 ed. Vol. 47. p. 477 478 p. (European Journal of Nuclear Medicine and Molecular Imaging ; vol. 47, no. Supplement 1).

  Research output › peer-review

  Open Access

• Low temperature radiolabelling of human serum albumin constructs with terbium-161 and ex vivo biodistribution to assess in vivo stability

  Cassells, I., Ooms, M., Burgoyne, A., Cornelis, J., Ahenkorah, S., Van de Voorde, M., Cardinaels, T., Deroose, C., Bormans, G. & Cleeren, F., 30 Oct 2020, European Journal of Nuclear Medicine and Molecular Imaging. p. S753 1 p. OP-151. (European Journal of Nuclear Medicine and Molecular Imaging; vol. 47, no. Supplement 1).

  Research output › peer-review

  Open Access

• Radiolabeling with Tb-161 and Lu-177: defining the impact of metal impurities

  Ooms, M., Burgoyne, A., Ponsard, B., Elema, D., Cardinaels, T. & Van de Voorde, M., 30 Oct 2020, European Journal of Nuclear Medicine and Molecular Imaging. Supplement 1 ed. Vol. 47. p. 677 1 p. EP-340. (European Journal of Nuclear Medicine and Molecular Imaging ).

  Research output › peer-review

  Open Access

• Supported ionic liquid phases for the separation of samarium and europium in nitrate media: Towards purification of medical samarium-153

  Van de Voorde, M., Van Hecke, K., Binnemans, K. & Cardinaels, T., Jan 2020, In: Separation and Purification Technology. 232, p. 1-10 10 p., 115939.

  Research output › peer-review

  Open Access
• 2019

  Radiochemical processing of nuclear-reactor-produced radiolanthanides for medical applications

  Van de Voorde, M., Van Hecke, K., Cardinaels, T. & Binnemans, K., 1 Mar 2019, In: Coordination Chemistry Reviews. 382, p. 103-125 23 p.

  Research output › peer-review

• Stability of europium(II) in aqueous nitrate media

  Van de Voorde, M., Geboes, B., Van Hecke, K., Cardinaels, T., Vander Hoogerstraete, T. & Binnemans, K., 5 Sep 2019, In: Dalton Transactions. 48, 39, p. 14758-14768 11 p.

  Research output › peer-review

  Open Access
• 2018

  Separation of samarium and europium by solvent extraction with an undiluted quaternary ammonium ionic liquid: towards high-purity medical samarium-153

  Van de Voorde, M., Van Hecke, K., Cardinaels, T. & Binnemans, K., 24 May 2018, In: RSC Advances. 8, p. 20077-20086 10 p.

  Research output › peer-review

  Open Access